Pharming Group N.V. (PHAR)

Pharming Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	362.27	297.2	245.32	205.62	198.87	212.17
Revenue Growth (YoY)	26.78%	21.15%	19.30%	3.40%	-6.27%	12.03%
Cost of Revenue	36.58	35.4	25.21	17.56	21.14	23.54
Gross Profit	325.7	261.8	220.1	188.06	177.73	188.64
Selling, General & Admin	198.25	184.43	175.26	127.44	90.97	75.69
Research & Development	88.43	83.15	68.66	52.53	65.38	38.52
Other Operating Expenses	-2.45	-2.18	-2.07	-2.28	-2.62	-1.83
Operating Expenses	284.24	265.4	241.85	177.69	153.73	112.38
Operating Income	41.46	-3.59	-21.75	10.37	24	76.26
Interest Expense	-14.3	-8.74	-5.96	-5.36	-6.09	-5.94
Interest & Investment Income	2.85	4.86	3.66	0.09	0.05	0.72
Earnings From Equity Investments	-0.76	-1.76	-0.29	-1.08	0.69	0.36
Currency Exchange Gain (Loss)	1.99	1.99	-2.97	4.4	14.84	-19.23
Other Non Operating Income (Expenses)	-1.38	3.78	-1.06	-1.29	-0.09	-0.07
EBT Excluding Unusual Items	29.85	-3.47	-28.38	7.12	33.4	52.08
Gain (Loss) on Sale of Investments	-	-	-	12.24	0.11	0.07
Gain (Loss) on Sale of Assets	-	-	21.28	-	-	-
Asset Writedown	-5.03	-5.03	-4.92	-4.38	-10.44	-
Other Unusual Items	-	-	-	-	-	-8.06
Pretax Income	14.73	-8.49	-12.01	14.99	23.08	44.09
Income Tax Expense	14.66	3.35	-1.46	1.31	7.08	6.35
Net Income	0.38	-11.84	-10.55	13.67	16	37.75
Net Income to Common	0.38	-11.84	-10.55	13.67	16	37.75
Net Income Growth	-	-	-	-14.52%	-57.62%	-6.93%
Shares Outstanding (Basic)	635	671	657	649	642	636
Shares Outstanding (Diluted)	635	671	657	707	701	683
Shares Change (YoY)	-2.65%	2.18%	-7.09%	0.85%	2.70%	1.37%
EPS (Basic)	0.00	-0.02	-0.02	0.02	0.02	0.06
EPS (Diluted)	0.00	-0.02	-0.02	0.02	0.02	0.05
EPS Growth	-	-	-	-17.39%	-58.18%	-9.84%
Free Cash Flow	52.72	-2.59	-18.74	21.08	27.1	78.97
Free Cash Flow Per Share	0.08	-0.00	-0.03	0.03	0.04	0.12
Gross Margin	89.90%	88.09%	89.72%	91.46%	89.37%	88.91%
Operating Margin	11.44%	-1.21%	-8.87%	5.04%	12.07%	35.94%
Profit Margin	0.10%	-3.98%	-4.30%	6.65%	8.04%	17.79%
Free Cash Flow Margin	14.55%	-0.87%	-7.64%	10.25%	13.63%	37.22%
EBITDA	47.91	3.22	-15.29	17.13	30.39	82.54
EBITDA Margin	13.23%	1.08%	-6.23%	8.33%	15.28%	38.90%
D&A For EBITDA	6.46	6.82	6.46	6.76	6.39	6.29
EBIT	41.46	-3.59	-21.75	10.37	24	76.26
EBIT Margin	11.44%	-1.21%	-8.87%	5.04%	12.07%	35.94%
Effective Tax Rate	99.53%	-	-	8.76%	30.69%	14.40%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q